Properties and benefits investigated
GHRH-pathway stimulation and ghrelin-receptor signaling; GH-axis research. Tesamorelin monotherapy results cannot establish the benefits, safety or added value of combining it with ipamorelin.
AVITUS RESEARCHTesamorelin + Ipamorelin
GH Secretagogues
Tesamorelin + Ipamorelin
GHRH analog paired with a ghrelin-receptor agonist, studied for GH-axis signaling.
- Research category
- GH Secretagogues
- Intended context
- Laboratory research only
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Evidence and limitations
The cited evidence concerns individual ingredients or related fragments. No controlled study of this exact Avitus blend was identified; synergy and clinical benefits remain unestablished.
References
PMID: 25038357, 9849822
Product specifications.
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.